|
|
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy. |
| 1 R01 CA249988-01A1 |
|
NCI |
2021 |
|
|
Multifunctional VAD Technology for High-Risk Pediatric Patients |
| 5 R01 HL153536-02 |
|
NHLBI |
2021 |
|
|
Catheter Based Cardiovascular Device Retrieval System |
| 5 R42 HL139309-03 |
|
NHLBI |
2021 |
|
|
Automated 3D Ultrasound-based Surveillance of Arteriovenous Fistula Maturation for Post-operative Hemodialysis Patients |
| 5 R44 HL147423-06 |
|
NHLBI |
2021 |
|
|
Design and characterization of Nanobodies to dementia-related α-synuclein strains in Parkinson’s disease |
| 1 R21 AG072009-01 |
|
NIA |
2021 |
|
|
Dissect the interplay between sex and APOE at the single cell level to uncover novel pathways, targets and therapeutics for Alzheimer's disease |
| 1 RF1 AG074010-01 |
|
NIA |
2021 |
|
|
Alzheimers Disease Hallmark Pathology and Associated Inflammation in the Retina |
| 5 R01 AG055865-04 |
|
NIA |
2021 |
|
|
An Integrative Multi-Omics Approach to Elucidate Sex-Specific Differences in Alzheimers Disease |
| 5 R01 AG060393-04 |
|
NIA |
2021 |
|
|
Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimers Disease over 18 Months |
| 5 R01 AG065248-02 |
|
NIA |
2021 |
|
|
Accelerated non-atherosclerotic brain arterial aging relationship to Alzheimers disease |
| 5 R01 AG066162-03 |
|
NIA |
2021 |
